Attana AB (publ) (NGM:ATANA)

Market Cap	21.12M
Revenue (ttm)	6.13M
Net Income (ttm)	-10.90M
Shares Out	1.92B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,873,355
Average Volume	25,058,209
Open	n/a
Previous Close	0.0100
Day's Range	n/a
52-Week Range	0.0050 - 0.0350
Beta	1.06
RSI	49.29
Earnings Date	Feb 24, 2026

About Attana AB

Attana AB (publ) provides analytical instruments and services for validating, selecting, and optimizing drug candidates primarily in Sweden. The company offers contract research services; in vitro diagnostic tools; analytical instruments; and Attana virus analytics. It serves pharmaceutical and biotechnology companies, and academic institutions. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden.

• Industry: Commercial Physical and Biological Research
• Founded: 2002
• Employees: 6
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ATANA

Financial Performance

In 2024, Attana AB's revenue was 6.61 million, a decrease of -3.02% compared to the previous year's 6.82 million. Losses were -12.78 million, -7.33% less than in 2023.